Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC 4.0Case Reports in Oncology

Primary Leiomyosarcoma of the Breast: A Case with Rapidly Progressive Clinical Course

6 affiliations
  1. 1Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, Tokyo, Japan
  2. 2Department of Breast Surgery, National Cancer Center Hospital East, Chiba, Japan
  3. 3Department of Surgery, Otakanomori Hospital, Chiba, Japan
  4. 4Department of Plastic and Reconstructive Surgery, National Cancer Center Hospital East, Chiba, Japan
  5. 5Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan
  6. 6Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan

Abstract

Introduction: Primary leiomyosarcoma (LMS) of the breast is an exceptionally rare mesenchymal malignancy that accounts for <0.0006% of all breast neoplasms. Owing to its rarity and the nonspecific nature of conventional imaging, achieving an accurate preoperative diagnosis is often difficult.

Case Presentation: We report the case of a 59-year-old woman who presented with a rapidly enlarging right breast mass. Clinical and radiographic evaluations revealed a large, irregular tumor involving the entire breast parenchyma (17 × 16 × 12 cm), without evidence of axillary lymphadenopathy or distant metastasis. A core needle biopsy revealed a malignant spindle cell neoplasm. The patient subsequently underwent total mastectomy with axillary sampling and skin grafting. Histological examination revealed a high-grade tumor composed of pleomorphic spindle cells with hemorrhage and necrosis. Immunohistochemical profiling showed that the tumor was negative for epithelial markers (AE1/AE3, EMA, and CAM5.2). However, the diffuse expression of α-smooth muscle actin and focal weak positivity for h-caldesmon confirmed a smooth muscle lineage. The Ki-67 labeling index was 50–60%. No lymph node metastasis was observed. Despite receiving adjuvant radiotherapy, the patient developed multiple pulmonary metastases 6 months post-surgery.

Conclusion: Primary breast LMS remains a diagnosis of exclusion, requiring differentiation from metaplastic carcinoma, phyllodes tumor, and metastatic sarcoma. Complete surgical resection remains the mainstay of treatment, and tumor size, grade, and Ki-67 index are critical prognostic factors.

Related

  1. Rapidly Progressive Acute Limb Ischemia With Irreversible Gangrene and Major Amputation in a Resource-Limited Setting: A Case Report
    Sai Say Han
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. From Unexplained Iron-Deficiency Anaemia to Ileo-Ileal Intussusception: A Case Report of Primary Small Bowel Leiomyosarcoma
    Manas M Potdar, Amanda Barden, Kopinath Kathirvetpillai +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. A Rapidly Progressive Case of Crimean-Congo Hemorrhagic Fever in Pregnancy Presenting with HELLP-Like Features and Resulting in Maternal and Fetal Death
    Handan Alay, Rumeysa Temur-Çelik, Fatma Kesmez-Can +4
    Infectious diseases & clinical microbiologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Primary Intratesticular Leiomyosarcoma: A Case Report and Literature Review.
    Selim Yazar, Recep Bedir, Gülen Burakgazi +4
    Journal of clinical practice and researchPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMCPMC
  5. Infective Endocarditis Presenting with Rapidly Progressive Cerebral Microbleeds and Multiple Intracerebral Hemorrhages: A Case Report
    Kazumasa Sekiguchi, Jun Sawada, Kosuke Matsuzono +5
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthJ-STAGE
BibTeX
@article{yamamoto2026primary,
  title = {{Primary Leiomyosarcoma of the Breast: A Case with Rapidly Progressive Clinical Course}},
  author = {Asako Yamamoto and Rurina Watanuki and Junko Kikuchi and Miki Yamada and Chisako Yamauchi and Azusa Oshima and Hiromichi Nakajima and Hiroki Imada and Takuya Higashino and Toru Mukohara and Genichiro Ishii and Tatsuya Onishi},
  journal = {Case Reports in Oncology},
  year = {2026},
  month = aug,
  doi = {10.1159/cro/abzag005},
  url = {https://doi.org/10.1159/cro/abzag005},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Primary Leiomyosarcoma of the Breast: A Case with Rapidly Progressive Clinical Course
AU  - Asako Yamamoto
AU  - Rurina Watanuki
AU  - Junko Kikuchi
AU  - Miki Yamada
AU  - Chisako Yamauchi
AU  - Azusa Oshima
AU  - Hiromichi Nakajima
AU  - Hiroki Imada
AU  - Takuya Higashino
AU  - Toru Mukohara
AU  - Genichiro Ishii
AU  - Tatsuya Onishi
PY  - 2026
DA  - 2026/08/05
JO  - Case Reports in Oncology
DO  - 10.1159/cro/abzag005
UR  - https://doi.org/10.1159/cro/abzag005
AB  - Introduction: Primary leiomyosarcoma (LMS) of the breast is an exceptionally rare mesenchymal malignancy that accounts for <0.0006% of all breast neoplasms. Owing to its rarity and the nonspecific nature of conventional imaging, achieving an accurate preoperative diagnosis is often difficult.  Case Presentation: We report the case of a 59-year-old woman who presented with a rapidly enlarging right breast mass. Clinical and radiographic evaluations revealed a large, irregular tumor involving the entire breast parenchyma (17 × 16 × 12 cm), without evidence of axillary lymphadenopathy or distant metastasis. A core needle biopsy revealed a malignant spindle cell neoplasm. The patient subsequently underwent total mastectomy with axillary sampling and skin grafting. Histological examination revealed a high-grade tumor composed of pleomorphic spindle cells with hemorrhage and necrosis. Immunohistochemical profiling showed that the tumor was negative for epithelial markers (AE1/AE3, EMA, and CAM5.2). However, the diffuse expression of α-smooth muscle actin and focal weak positivity for h-caldesmon confirmed a smooth muscle lineage. The Ki-67 labeling index was 50–60%. No lymph node metastasis was observed. Despite receiving adjuvant radiotherapy, the patient developed multiple pulmonary metastases 6 months post-surgery.  Conclusion: Primary breast LMS remains a diagnosis of exclusion, requiring differentiation from metaplastic carcinoma, phyllodes tumor, and metastatic sarcoma. Complete surgical resection remains the mainstay of treatment, and tumor size, grade, and Ki-67 index are critical prognostic factors.
SN  - 1662-6575
ER  -